Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company specializing in pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company produces high-purity intermediates for API production and APIs used in formulations for medicines, nutraceuticals, personal care, and veterinary products, adhering to Indian and international pharmacopeia standards such as IP, BP, EP, JP, and USP.

Beyond standard manufacturing, Anlon Healthcare offers custom manufacturing of complex chemicals, achieving purity levels above industry standards and minimizing impurities to meet specific customer requirements. The company has received Drug Master File (DMF) approvals from ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs. It has filed 21 DMFs globally and is pursuing approvals for Ketoprofen and Dexketoprofen Trometamol.

Quality is ensured through rigorous testing, analysis, and continuous process improvements. Supported by four laboratories, a 34-member team (including 24 science graduates) ensures that products meet stringent customer and regulatory standards. The company’s portfolio comprises 65 commercialized products, 28 at pilot stage, and 49 at laboratory scale testing stage.

Products:

Pharma Intermediates: Cyanoethylbenzoic acid, Ketonitrile, Methyldesloratadine, serving as key starting materials or advanced intermediates for APIs.

Active Pharmaceutical Ingredients (APIs): Core components in pharmaceuticals, used in tablets, capsules, ointments, syrups, as well as in nutraceuticals, personal care, and veterinary products.

Competitive Strengths:

Strong and scalable product portfolio

Experienced promoters and management team

High entry and exit barriers due to long customer approval cycles and strict quality standards

In-house testing, quality control, and quality assurance

Commitment to quality, environment, health, and safety